Skip to main content
Scientist at sterile bench

Cluster of Excellence ImmunoSensation²

Immunology as a key to better health

ImmunoSensation2 is a Cluster of Excellence at the University of Bonn funded by the German Research Foundation (DFG). We are dedicated to the study of innate immunity beyond the boundaries of classical immunology. We address the immune system as a sensory organ for health, which we term the immune sensory system. We are immunologists, neurobiologists, systems biologists, biochemists, biophysicists and mathematicians from the Faculty of Medicine and the Faculty of Mathematics and Natural Sciences at the University of Bonn, the University Hospital Bonn (UKB) and the German Centre for Neurodegenerative Diseases (DZNE) of the Helmholtz Association.

Founded in 2012, ImmunoSensation2 is currently in its fourteenth year of funding. We will continue to pursue our mission of innovative science in immunology. Further, we link immunology to other systems, such as the metabolic system and the nervous system. Ultimately, we want to better understand the intimate connection between the immune sensory system and human health and disease. The cluster will contiune as ImmunoSensation³ for a funding period of another 7 years, starting 2026, taking immune diversity into focus.

Members & Publications


Members

Members database


Publications

Publications database

News

Symbol Image

Publication

Instructions for building antibodies decoded

—MOG Antibody-associated Disease (MOGAD) is a rare autoimmune disease of the central nervous system. The blood of patients contains antibodies against myelin oligodendrocyte glycoprotein (MOG), a protein in the myelin layer that surrounds the neurons in the brain. It is believed that these antibodies contribute to the destruction of this protective layer in the brain. Researchers at the University Hospital Bonn (UKB) and the Universities of Basel and Bonn, in collaboration with an international team, have now deciphered the construction plan of the anti-MOG antibodies.
View entry
News Icon

Publication

A fatal mix-up: how certain gut bacteria drive multiple sclerosis

—If gut bacteria are too similar to the protective layer of nerves, they can misdirect the immune system and cause it to attack its own nervous system. This mechanism can accelerate the progression of multiple sclerosis, as researchers at the University of Basel, together with colleagues in Bonn, have shown in trials with mice. However, their results also open up opportunities for treatments that make use of the microbiome. The results have now been published in the journal Gut Microbes.
View entry
News Icon

Publication

New vulnerability of asthma immune cells discovered

—Why do certain immune cells remain permanently active in allergic asthma – even in an environment that should actually damage them? A team from the University Hospital Bonn (UKB) and the University of Bonn has discovered that these cells only survive because they activate a special antioxidant protection mechanism. When this mechanism is blocked, allergic inflammation in mouse models decreases significantly. The results have now been published in the scientific journal Immunity.
View entry
News overview

Upcoming events

  • Workshop Online

    SciCom Focus: Video

     –

    online (zoom)

    The "SciCom Workshop Series" equips PhD students and postdocs with practical tools to present their work clearly and confidently across formats: writing and media to stage and video.

Events overview

Insights

Immunosensation 360°

Follow us on a virtual tour into the institutes and laboratories of ImmunoSensation2!

The 360° experience allows you to embark on an exciting journey, exploring the diversity of immunological research performed at ImmunoSensation2. Let our scientists guide you through the sites of scientific excellence and introduce you to the amazing world of the immune system.

Multimedia report "Beyond the Boundaries"

In our multimedia report "Beyond the boundaries" we introduce some of our outstanding group leaders. We take a closer look on their scientific work and their career paths within ImmunoSensation2, highlighting their innovative research approaches as well as the excellent research environment at the University of Bonn.

 

The report introduces